drug

sigvotatug vedotin

1 story · latest Aug 4, 2026

Status: Investigational
Codes: PF-08046047, SGN-B6A
Trials: 4 registered trials in coverage

Relationships

Developed by Pfizer

Timeline

Pfizer raises 2026 revenue outlook, reports Q2 loss on impairment charges

Aug 4Quarterly updatePfizer

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.